PTEN and small cell lung carcinoma: For example, PTEN is an inhibitor of the PI3K–AKT–mTOR pathway, and its inactivation leads to accelerating SCLC growth and increasing metastases in a Trp53 and Rb1-inactivated deleted system (Cui et al., 2014).